These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 16911191

  • 1. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C, Nishimura H, Sanaka T.
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [Abstract] [Full Text] [Related]

  • 2. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M, Keuning ED, ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J.
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [Abstract] [Full Text] [Related]

  • 3. Glucotoxicity in peritoneal dialysis--solutions for the solution!
    Holmes CJ.
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):269-78. PubMed ID: 17603981
    [Abstract] [Full Text] [Related]

  • 4. [Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement].
    Olszowska A, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):364-7. PubMed ID: 18634375
    [Abstract] [Full Text] [Related]

  • 5. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K, Khanna R.
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [Abstract] [Full Text] [Related]

  • 6. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L, Topley N, Cooker L, Dawnay A, Millar DJ, Holmes CJ, Faict D.
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [Abstract] [Full Text] [Related]

  • 7. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M.
    Wien Klin Wochenschr; 2005 Dec; 117 Suppl 6():89-97. PubMed ID: 16437339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M, De Vriese AS, Hekking LH, ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [Abstract] [Full Text] [Related]

  • 11. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, Choi MJ, Kim IS, Park MS, Kim YJ, Kim YL.
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
    Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid.
    Ogata S, Yorioka N, Kiribayashi K, Naito T, Kuratsune M, Nishida Y.
    Adv Perit Dial; 2003 Sep; 19():2-5. PubMed ID: 14763024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.